News & Press
Slingshot Unveils a Novel Cell Therapy-Focused Portfolio to Streamline Development while Improving Manufacturing and Clinical Trial Capabilities
Slingshot Biosciences Announces Election of Nicolas Barthelemy as Executive Chair
Slingshot Biosciences Announces $11 Million in Series A3 Financing
Slingshot Biosciences, Inc. Partners with Palex Medical
Events
We look forward to meeting you in 2024!